If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

Share Price Information for Iconic Labs (ICON)

Share Price is delayed by 15 minutes
Get Live Data
1.75    -0.10 (-5.41%)
Bid:
1.60
Ask:
1.90
Spread: 0.30 (18.75%)
Market Cap: £287.18k
ICON Live PriceLast checked at - London Stock Exchange

Intraday Iconic Labs Share Chart

Director Appointment

20 Feb 2023 07:49

RNS Number : 4155Q
Iconic Labs PLC
20 February 2023
 

20 February 2023

 

Iconic Labs PLC

("Iconic" or the "Company")

Director Appointment

 

Iconic Labs PLC (LSE:ICON), is pleased to announce that Emmanuel Blouin has been appointed to the Board of Directors with immediate effect.

Mr. Blouin has 25 years of investment and banking experience. He was a senior banker with Morgan Stanley, JP Morgan and BNP Paribas, during which he was involved in over €50 billion of capital markets, corporate finance and property transactions across Europe. In 2008, Mr. Blouin established Esterel Capital, a London-based boutique focusing on real estate and finance, where he continues to be Managing Partner.

Mr. Blouin is also currently a director of Courbet SA, a hospitality investment company listed on the Paris Stock Exchange, as well as an Independent Non-Executive Director of Aradei Capital, a commercial property investment and management company listed on the Casablanca Stock Exchange.

The following information is disclosed about Mr. Emmanuel Blouin:

Current Directorships / Partnerships

Aradei Capital

Courbet SA

Esterel Capital LLP

Stanrock Capital Ltd

Squareconcept Property Management Ltd

Previous Directorships / Partnerships held in the past 5 years: None

Brad Taylor, CEO of Iconic Labs, commented:

"I welcome Emmanuel to the Iconic board of directors. He is a highly skilled professional with significant expertise in corporate finance and international dealmaking. This experience, coupled with his vast network, will serve Iconic and its shareholders well as the company develops and implements an acquisition and growth strategy. With Iconic directors now in the United States, United Kingdom, and Europe, we are well-positioned to maximize our potential for value creation."

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

- ENDS -

 

For any further information or enquiries please contact:

 

ir@iconiclabs.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADBLBLXLLZBBK
Date   Source Headline
21st Sep 202011:22 amRNSTR-1 notification
21st Sep 20209:53 amRNSTR-1 notification
18th Sep 202012:00 pmRNSIssue of Equity and Pay-down of Existing Debt
18th Sep 202011:06 amRNSSecond Price Monitoring Extn
18th Sep 202011:00 amRNSPrice Monitoring Extension
18th Sep 20209:05 amRNSSecond Price Monitoring Extn
18th Sep 20209:00 amRNSPrice Monitoring Extension
18th Sep 20208:36 amRNSOperations and Financing Update
16th Sep 20204:41 pmRNSSecond Price Monitoring Extn
16th Sep 20204:36 pmRNSPrice Monitoring Extension
16th Sep 20202:05 pmRNSSecond Price Monitoring Extn
16th Sep 20202:00 pmRNSPrice Monitoring Extension
16th Sep 202012:37 pmRNSTR-1 notification
15th Sep 20204:41 pmRNSSecond Price Monitoring Extn
15th Sep 20204:36 pmRNSPrice Monitoring Extension
14th Sep 20204:08 pmRNSTR-1 notification
14th Sep 20204:07 pmRNSTR-1 notification
11th Sep 20202:05 pmRNSSecond Price Monitoring Extn
11th Sep 20202:00 pmRNSPrice Monitoring Extension
11th Sep 202011:05 amRNSSecond Price Monitoring Extn
11th Sep 202011:00 amRNSPrice Monitoring Extension
10th Sep 202011:46 amRNSFinance Update and Intention to replace facility
10th Sep 20207:00 amRNSNew contract and update on JOE Media contract
8th Sep 20204:40 pmRNSSecond Price Monitoring Extn
8th Sep 20204:35 pmRNSPrice Monitoring Extension
8th Sep 20202:05 pmRNSSecond Price Monitoring Extn
8th Sep 20202:00 pmRNSPrice Monitoring Extension
8th Sep 20209:18 amRNSTR-1 notification
8th Sep 20207:00 amRNSIssue of Equity and Pay-down of debt
4th Sep 20202:05 pmRNSSecond Price Monitoring Extn
4th Sep 20202:00 pmRNSPrice Monitoring Extension
4th Sep 202011:06 amRNSSecond Price Monitoring Extn
4th Sep 202011:00 amRNSPrice Monitoring Extension
4th Sep 20209:35 amRNSTR-1 notification
1st Sep 20207:00 amRNSTR-1 notification
26th Aug 20204:31 pmRNSTR-1 notification
25th Aug 202010:03 amRNSTR-1 notification
25th Aug 20207:00 amRNSIssue of Equity and Pay-down of Debt
24th Aug 20204:01 pmRNSTR -1 notification
20th Aug 20202:05 pmRNSSecond Price Monitoring Extn
20th Aug 20202:00 pmRNSPrice Monitoring Extension
19th Aug 20209:00 amRNSTR-1 notification
19th Aug 20209:00 amRNSTR-1 notification
17th Aug 20203:12 pmRNSIssue of Equity and Pay-Down of Debt
14th Aug 20209:35 amRNSTR-1 notification
13th Aug 20204:40 pmRNSSecond Price Monitoring Extn
13th Aug 20204:35 pmRNSPrice Monitoring Extension
11th Aug 20209:57 amRNSTR-1 notification
10th Aug 202010:15 amRNSTR-1 notification
5th Aug 20207:00 amRNSNew £150,000 contract through management agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.